Vasoconstrictive effects of native tachykinins in the rainbow trout, Oncorhynchus mykiss.
The role of trout substance P (tSP) and neurokinin A (tNKA) in cardiovascular regulation was investigated in the rainbow trout, Oncorhynchus mykiss, in vivo and in vitro. In vivo, the coeliac arterial and ventral aortic relative blood flows were measured with Doppler flow probes, and blood pressure was measured via a cannula inserted into the dorsal aorta. tSP (0.1 and 1 nmol kg-1) and tNKA (1 nmol kg-1) increased both systemic and coeliac vascular resistances, leading to hypertension and bradycardia. In addition, cardiac output was decreased. The mammalian NK1 tachykinin receptor antagonist CP-96,345 did not affect the responses to tSP or tNKA. In vitro perfusions of the dorsal aortic and coeliacomesenteric vascular beds were performed using peristaltic pumps. The dorsal aortic vascular resistance was dose-dependently increased following infusion of the two peptides (pD2 values 7.6 +/- 0.1 and 7.3 +/- 0.1 for tSP and tNKA, respectively). Tetrodotoxin did not affect the tSP-induced hypertension. Increases in coeliac vascular resistance caused by tSP was correlated with stomach contractions when measurement of intragastric pressure was made using an inserted balloon. In conclusion, native SP and NKA are potent vasoconstrictors of rainbow trout vasculature, a property quite unusual to tachykinins compared with the vasodilation normally seen in mammals.
Kågström
J
J
Department of Zoophysiology, Göteborg University, Sweden.
Holmgren
S
S
Olson
K R
KR
Conlon
J M
JM
Jensen
J
J
D000595:Amino Acid Sequence; D000818:Animals; D002320:Cardiovascular Physiological Phenomena; D002319:Cardiovascular System / Q000187:drug effects; D008322:Mammals; D008969:Molecular Sequence Data; D015288:Neurokinin A / Q000235:genetics / Q000494:pharmacology / Q000502:physiology; D017686:Oncorhynchus mykiss / Q000502:physiology*; D010477:Perfusion; D013045:Species Specificity; D013373:Substance P / Q000235:genetics / Q000494:pharmacology / Q000502:physiology; D015320:Tachykinins / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D015320:Tachykinins; D014662:Vasoconstrictor Agents; D013373:Substance P; D015288:Neurokinin A